Patents by Inventor Assaf Marcus

Assaf Marcus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOTHERAPY USING REDIRECTED ALLOGENEIC CELLS
    Publication number: 20170216356
    Abstract: A method of treating a disease, such as cancer, by administering to a subject in need of such treatment an effective amount of allogeneic T cells with a MHC unrestricted chimeric receptor short time after partial lymphodepletion. The method also comprises administering one or more agents that delay egression of the allogeneic T cells from lymph nodes of said subject during adoptive transfer of said allogeneic T cells to the subject by trapping the T cells in the lymph nodes.
    Type: Application
    Filed: February 14, 2017
    Publication date: August 3, 2017
    Inventors: Zelig ESHHAR, Assaf MARCUS, Tova WAKS
  • Immunotherapy using redirected allogeneic cells
    Patent number: 9623049
    Abstract: A method of treating a disease, such as cancer, by administering to a subject in need of such treatment an effective amount of allogeneic T cells with a MHC unrestricted chimeric receptor short time after partial lymphodepletion. The method also comprises administering one or more agents that delay egression of the allogeneic T cells from lymph nodes of said subject during adoptive transfer of said allogeneic T cells to the subject by trapping the T cells in the lymph nodes.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: April 18, 2017
    Assignee: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Zelig Eshhar, Assaf Marcus, Tova Waks